Showing results (241-250 of 491) with videos related to
Sort By:
Pageof 50
European Journal of Pharmacology|April 10, 2009
Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseasesTaketoshi Ogawa, Masami Hashimoto, Yoichi Niitsu, et al.Radiation Research|May 14, 2019
Use of Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health EmergencyAndrea L DiCarlo, Zulmarie Perez Horta, Jennifer T Aldrich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.The Journal of Infectious Diseases|August 14, 2021
Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell-Depleted Hematopoietic Cell TransplantYeon Joo Lee, Yiqi Su, Christina Cho, et al.European Journal of Pharmacology|August 28, 2007
Study of plasma protein C and inflammatory pathways: biomarkers for dimethylnitrosamine-induced liver fibrosis in ratsJoy K Saha, Jinqi Xia, George E Sandusky, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipientsMini Kamboj, Dick Chung, Susan K Seo, et al.Journal of the American Heart Association|May 17, 2013
P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activityMichelle A Berny-Lang, Joseph A Jakubowski, Atsuhiro Sugidachi, et al.Pediatrics|June 18, 2014
Firearm homicide and other causes of death in delinquents: a 16-year prospective studyLinda A Teplin, Jessica A Jakubowski, Karen M Abram, et al.Platelets|June 14, 2006
Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humansFumitoshi Asai, Joseph A Jakubowski, Hideo Naganuma, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 18, 2016
The Rationale for and Clinical Pharmacology of Prasugrel 5 mgJoseph A Jakubowski, David Erlinge, Dimitrios Alexopoulos, et al.Pageof 50